• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Coinbase, Moderna And 56 Biggest Movers From Yesterday

    7/7/22 4:42:34 AM ET
    $AHG
    $AMTI
    $AMZN
    $AREN
    Real Estate
    Real Estate
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AHG alert in real time by email

    Gainers

    • Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) shares climbed 75.2% to close at $2.19 after the company announced it has developed a non-invasive blood sensor designated to alert real-time change in patients' clinical condition.
    • Waitr Holdings Inc. (NASDAQ:WTRH) gained 73.2% to settle at $0.2654.
    • Resolute Forest Products Inc. (NYSE:RFP) shares climbed 63% to close at $20.36 after The Paper Excellence Group announced an agreement to acquire the company.
    • Kalera Public Limited Company (NASDAQ:KAL) shares gained 57.5% to close at $4.41 after dipping 22% on Tuesday.
    • Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) gained 48.8% to settle at $0.90 after the company announced FDA clearance of its IND application for nalmefene implant.
    • Revelation Biosciences, Inc. (NASDAQ:REVB) jumped 44.4% to close at $1.20.
    • Enjoy Technology, Inc. (NASDAQ:ENJY) climbed 35.2% to close at $0.4190 after jumping more than 80% on Tuesday.
    • ThermoGenesis Holdings, Inc. (NASDAQ:THMO) gained 30.8% to settle at $0.3022. ThermoGenesis reported in a filing Tuesday that it received a conversion notice from Boyalife Asset Holding II to convert a total of $3m of the outstanding balance of the second amended and restated convertible promissory note issued to Boyalife on April 16, 2018.
    • Mynaric AG (NASDAQ:MYNA) jumped 29.2% to close at $8.56 after the company announced a 7.2% stake by L3Harris.
    • MediaCo Holding Inc. (NASDAQ:MDIA) gained 29.1% to settle at $2.66.
    • Zevia PBC (NYSE:ZVIA) climbed 26.2% to close at $3.56.
    • Vigil Neuroscience, Inc. (NASDAQ:VIGL) shares gained 25.7% to close at $3.08.
    • Scholar Rock Holding Corporation (NASDAQ:SRRK) climbed 21.8% to close at $7.16.
    • PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS) rose 21.4% to settle at $0.8002. PhaseBio Pharmaceuticals received notice from Nasdaq of noncompliance with Nasdaq minimum bid price requirement listing rule.
    • Shattuck Labs, Inc. (NASDAQ:STTK) jumped 20.9% to settle at $5.20.
    • Evofem Biosciences, Inc. (NASDAQ:EVFM) rose 20.9% to close at $1.33.
    • Seelos Therapeutics, Inc. (NASDAQ:SEEL) surged 20.5% to settle at $0.89.
    • Genetic Technologies Limited (NASDAQ:GENE) gained 20.3% to close at $1.54.
    • Symbotic Inc. (NASDAQ:SYM) jumped 20.3% to close at $17.28, possibly on continued strength after Raymond James on Tuesday initiated coverage on the stock with an Outperform rating and $18 price target.
    • First Wave BioPharma, Inc. (NASDAQ:FWBI) gained 19.7% to close at $0.2490.
    • SCWorx Corp. (NASDAQ:WORX) gained 19.4% to close at $0.7401 after the company reported a common stock purchase agreement with institutional investor on Tuesday.
    • Engine Gaming and Media, Inc. (NASDAQ:GAME) rose 18.5% to close at $1.09. Engine Gaming and Media is expected to release fiscal third quarter results on Thursday, July 14, 2022.
    • Onion Global Limited (NYSE:OG) surged 18.4% to close at $1.02.
    • Uxin Limited (NASDAQ:UXIN) jumped 18% to settle at $0.66 after surging 24% on Tuesday. Uxin recently announced its entry into definitive agreements for financing transaction of $100 million in replacement of the previously announced binding term sheet.
    • Organovo Holdings, Inc. (NASDAQ:ONVO) gained 17.7% to close at $2.13.
    • Beyond Air, Inc. (NASDAQ:XAIR) rose 17.7% to close at $9.96. Beyond Air Director Robert Carey acquired a total of 175,000 shares at an average price of $6.45.
    • Omega Therapeutics, Inc. (NASDAQ:OMGA) gained 17.5% to settle at $4.77.
    • Cano Health, Inc. (NYSE:CANO) rose 17.1% to close at $5.63 amid speculation of Humana eyeing acquisition of Cano Health.
    • Humanigen, Inc. (NASDAQ:HGEN) gained 14.4% to close at $2.07.
    • Zomedica Corp. (NYSE:ZOM) jumped 13.9% to close at $0.2505. Zomedica received a notice of allowance for U.S. patent titled 'Compositions And Methods For Identifying Cancer Cells.'
    • Eos Energy Enterprises, Inc. (NASDAQ:EOSE) gained 13.5% to close at $1.43 after the company announced the signing of two orders with Bridgelink Commodities and a Northeast solar developer totaling 1.1 GWh of energy storage capacity, and said its backlog is now over $460 million.
    • Decibel Therapeutics, Inc. (NASDAQ:DBTX) rose 13.5% to close at $4.88. Decibel Therapeutics recently reported top-line results from an interim analysis of its ongoing Phase 1b clinical trial of DB-020.
    • Veru Inc. (NASDAQ:VERU) jumped 13% to close at $13.02. Veru announced New England Journal of Medicine evidence publication of Phase 3 clinical trial results demonstrating that sabizabulin treatment significantly reduced deaths in high-risk hospitalized COVID-19 patients.
    • Rivian Automotive, Inc. (NASDAQ:RIVN) gained 10.4% to close at $29.66 after the company announced it produced 4,401 vehicles and delivered 4,467 vehicles during Q2. The company said these figures remain in line with its expectations.
    • Digital Brands Group, Inc. (NASDAQ:DBGI) rose 6% to close at $0.2090.
    • Moderna, Inc. (NASDAQ:MRNA) gained 2.6% to close at $159.56 in possible reaction to recent WHO comments stating global COVID-19 cases are up 30% over the last two weeks.


    Losers

    • Kornit Digital Ltd. (NASDAQ:KRNT) shares fell 25.7% to close at $23.46 after the company issued preliminary Q2 sales guidance below estimates. Multiple analysts also lowered their price targets on the stock.
    • Applied Molecular Transport Inc. (NASDAQ:AMTI) fell 25.6% to close at $2.32 after the company announced top-line Phase 2 results from its MARKET combination trial of oral AMT-101 in patients with moderate-to-severe ulcerative colitis.
    • Nuwellis, Inc. (NASDAQ:NUWE) fell 23.3% to close at $0.69. Nuwellis recently said that first patient was enrolled in pivotal trial REVERSE-HF.
    • Yatsen Holding Limited (NYSE:YSG) fell 18% to close at $1.64.
    • Art's-Way Manufacturing Co., Inc. (NASDAQ:ARTW) dropped 17.1% to settle at $2.38. Art's-Way Manufacturing posted Q2 EPS of $0.04.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) dipped 15.9% to close at $0.1590. T2 Biosystems said it expects Q2 FY22 revenues of $5.8 million - $6.1 million, below the consensus of $6.87 million.
    • Connexa Sports Technologies Inc. (NASDAQ:CNXA) fell 15.7% to close at $1.24.
    • The Arena Group Holdings, Inc. (NASDAQ:AREN) dipped 15.4% to settle at $9.26.
    • Forge Global Holdings, Inc. (NYSE:FRGE) dropped 14.9% to close at $8.76.
    • Stratasys Ltd. (NASDAQ:SSYS) fell 14.8% to close at $16.20. As the market reopened following the long July 4 weekend, Cathie Wood-run Ark Invest made some portfolio moves, notable among which is the offloading of a huge chunk of Stratasys stake.
    • Dragon Victory International Limited (NASDAQ:LYL) dropped 14.7% to settle at $0.81.
    • RADA Electronic Industries Ltd. (NASDAQ:RADA) shares fell 14.2% to close at $7.76 after the company issued weak sales guidance for the second quarter.
    • Vacasa, Inc. (NASDAQ:VCSA) declined 12.6% to close at $2.77.
    • NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) shares fell 11% to close at $2.75. NeuroSense Therapeutics recently announced results from a biomarker study to evaluate the potential of CogniC, a combination drug for Alzheimer's disease (AD).
    • Ra Medical Systems, Inc. (NASDAQ:RMED) fell 9.1% to close at $0.3911. Ra Medical Systems shares jumped 39% on Tuesday after the company announced it has received FDA 510(k) clearance for its DABRA 2.0 catheter.
    • Ring Energy, Inc. (NYSE:REI) fell 8.2% to close at $2.35. Ring Energy recently announced agreement to acquire Stronghold's Permian Basin Assets.
    • Frontline Ltd. (NYSE:FRO) dropped 7.6% to close at $8.17.
    • DoorDash, Inc. (NYSE:DASH) dropped 7.4% to settle at $69.36 after Amazon.com Inc (NASDAQ:AMZN) acquired a 2% stake in competitor company Just Eat Takeaway's Grubhub.
    • Coinbase Global, Inc. (NASDAQ:COIN) fell 6.7% to settle at $51.71 after Atlantic Equities downgraded the stock from Overweight to Neutral and announced a $54 price target.
    • Centogene N.V. (NASDAQ:CNTG) dropped 6.7% to close at $2.4920.
    • Akso Health Group (NYSE:AHG) dropped 6.4% to close at $1.02.
    • NIO Inc. (NYSE:NIO) fell 6.1% to settle at $20.83 after Shanghai announced it will be conducting mass COVID-19 testing in several districts following a rise in cases.
    Get the next $AHG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AHG
    $AMTI
    $AMZN
    $AREN

    CompanyDatePrice TargetRatingAnalyst
    Amazon.com Inc.
    $AMZN
    2/6/2026$300.00 → $280.00Buy
    Monness Crespi & Hardt
    Amazon.com Inc.
    $AMZN
    2/6/2026$175.00Buy → Neutral
    DA Davidson
    Amazon.com Inc.
    $AMZN
    2/2/2026$300.00 → $315.00Mkt Outperform
    Citizens JMP
    Amazon.com Inc.
    $AMZN
    1/28/2026$305.00 → $315.00Outperform
    Oppenheimer
    Amazon.com Inc.
    $AMZN
    1/28/2026$303.00 → $308.00Overweight
    KeyBanc Capital Markets
    Shattuck Labs Inc.
    $STTK
    1/28/2026$15.00Overweight
    Piper Sandler
    Moderna Inc.
    $MRNA
    1/28/2026$25.00Equal Weight
    Barclays
    Coinbase Global Inc.
    $COIN
    1/28/2026$240.00Neutral
    Robert W. Baird
    More analyst ratings

    $AHG
    $AMTI
    $AMZN
    $AREN
    SEC Filings

    View All

    SEC Form 13F-HR filed by Amazon.com Inc.

    13F-HR - AMAZON COM INC (0001018724) (Filer)

    2/10/26 4:13:45 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form 6-K filed by Akso Health Group

    6-K - Akso Health Group (0001702318) (Filer)

    2/10/26 4:06:11 PM ET
    $AHG
    Real Estate

    SEC Form SCHEDULE 13G filed by Scholar Rock Holding Corporation

    SCHEDULE 13G - Scholar Rock Holding Corp (0001727196) (Subject)

    2/10/26 11:19:49 AM ET
    $SRRK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AHG
    $AMTI
    $AMZN
    $AREN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO and Director Kenna Justin converted options into 625,000 shares, increasing direct ownership by 60% to 1,661,936 units (SEC Form 4)

    4 - GameSquare Holdings, Inc. (0001714562) (Issuer)

    2/10/26 9:47:10 PM ET
    $GAME
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Chief Financial Officer Haas Alesia J exercised 78,433 shares at a strike of $18.13, sold $56,496,307 worth of shares (364,600 units at $154.95) and converted options into 617,668 shares, increasing direct ownership by 469% to 402,165 units (SEC Form 4)

    4 - Coinbase Global, Inc. (0001679788) (Issuer)

    2/10/26 5:36:30 PM ET
    $COIN
    Finance: Consumer Services
    Finance

    Large owner Invus Global Management, Llc exercised 1,575,008 in-the-money shares at a strike of $7.35 (SEC Form 4)

    4 - Scholar Rock Holding Corp (0001727196) (Issuer)

    2/6/26 5:35:54 PM ET
    $SRRK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AHG
    $AMTI
    $AMZN
    $AREN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Monness Crespi & Hardt reiterated coverage on Amazon with a new price target

    Monness Crespi & Hardt reiterated coverage of Amazon with a rating of Buy and set a new price target of $280.00 from $300.00 previously

    2/6/26 8:23:18 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Amazon downgraded by DA Davidson with a new price target

    DA Davidson downgraded Amazon from Buy to Neutral and set a new price target of $175.00

    2/6/26 8:06:19 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Citizens JMP reiterated coverage on Amazon with a new price target

    Citizens JMP reiterated coverage of Amazon with a rating of Mkt Outperform and set a new price target of $315.00 from $300.00 previously

    2/2/26 8:12:32 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AHG
    $AMTI
    $AMZN
    $AREN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Amazon One Medical Introduces Health Insights to Help Patients Better Understand Their Lab Results

    New beta feature transforms routine bloodwork results into personalized and actionable health information Amazon One Medical today announced the launch of Health Insights, a new beta feature that helps eligible members gain deeper understanding of their routine lab results through personalized analysis and evidence-based recommendations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260210765877/en/Explanation of patient lab results from Health Insights. Health Insights—developed in partnership with Lifeforce—addresses a growing patient need: as people increasingly want to understand and engage with their health data, they ne

    2/10/26 4:45:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Scholar Rock to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026

    Scholar Rock (NASDAQ:SRRK) today announced that it will report fourth quarter and full year 2025 financial results on Tuesday, March 3, 2026, before the financial markets open. The Company will host a conference call and webcast with Scholar Rock management at 8:00 a.m. ET. To access the live audio webcast, please go to "Events and Presentations" in the Investors section of the Scholar Rock website at http://investors.scholarrock.com. To participate via telephone, please register in advance here. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call. An archived replay of the webcast will be available on the Company's

    2/10/26 8:00:00 AM ET
    $SRRK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    NeuroSense Expands Global IP Protection Strategy With Granted Australian Patent Covering PrimeC Composition

    Strengthens Global IP Portfolio for PrimeC Through 2042 CAMBRIDGE, Mass., Feb. 9, 2026 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today announced that the Australian Patent Office (IP Australia) has granted Australian Patent No. 2022370513, entitled "Compositions Comprising Ciprofloxacin and Celecoxib," representing another strategic step in the continued expansion of the Company's global intellectual property protection for PrimeC. The granted Australian patent, following prior approval of the corresponding U.S. patent (12,097,185), further expands 

    2/9/26 9:20:00 AM ET
    $NRSN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AHG
    $AMTI
    $AMZN
    $AREN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Akkaraju Srinivas bought $1,181,634 worth of shares (29,599 units at $39.92) and exercised 1,064,804 in-the-money shares at a strike of $7.35 (SEC Form 4)

    4 - Scholar Rock Holding Corp (0001727196) (Issuer)

    12/16/25 9:07:57 PM ET
    $SRRK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Lin Alfred bought $100,277,150 worth of shares (514,047 units at $195.07) (SEC Form 4)

    4 - DoorDash, Inc. (0001792789) (Issuer)

    11/28/25 7:02:02 PM ET
    $DASH
    EDP Services
    Technology

    Director Akkaraju Srinivas bought $18,807,352 worth of shares (500,439 units at $37.58) (SEC Form 4)

    4 - Scholar Rock Holding Corp (0001727196) (Issuer)

    10/7/25 8:59:19 PM ET
    $SRRK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AHG
    $AMTI
    $AMZN
    $AREN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 11, 2025 - FDA Roundup: March 11, 2025

    For Immediate Release: March 11, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA published a General Correspondence Letter issued to Mid-Link Technology Testing Co., Ltd. The FDA is vigilant in ensuring data submitted to the FDA can be relied upon to assess the effectiveness, safety, or risk of a device. The FDA has noted an incr

    3/13/25 3:14:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    November 14, 2023 - FDA Roundup: November 14, 2023

    For Immediate Release: November 14, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, the FDA updated the advisory for the Investigation of Elevated Lead Levels in Cinnamon Applesauce Pouches to include an expanded recall from WanaBana LLC to include Weis and Schnucks-brand cinnamon applesauce pouches. As of November 13, 2023, there

    11/14/23 3:26:18 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    July 1, 2022 - FDA Roundup: July 1, 2022

    For Immediate Release: July 01, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced a request for nominations for consumer representatives to serve on advisory committees and panels for which vacancies currently exist or are expected to occur in the near future. The FDA relies on our many advisory committees to help us

    7/1/22 11:54:25 AM ET
    $XAIR
    Medical/Dental Instruments
    Health Care

    $AHG
    $AMTI
    $AMZN
    $AREN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Eos Energy Enterprises Inc.

    SC 13D/A - Eos Energy Enterprises, Inc. (0001805077) (Subject)

    12/17/24 2:48:02 PM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    SEC Form SC 13G filed by NeuroSense Therapeutics Ltd.

    SC 13G - NeuroSense Therapeutics Ltd. (0001875091) (Subject)

    12/9/24 4:00:18 PM ET
    $NRSN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Shattuck Labs Inc.

    SC 13D/A - Shattuck Labs, Inc. (0001680367) (Subject)

    12/6/24 9:03:38 PM ET
    $STTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AHG
    $AMTI
    $AMZN
    $AREN
    Financials

    Live finance-specific insights

    View All

    Scholar Rock to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026

    Scholar Rock (NASDAQ:SRRK) today announced that it will report fourth quarter and full year 2025 financial results on Tuesday, March 3, 2026, before the financial markets open. The Company will host a conference call and webcast with Scholar Rock management at 8:00 a.m. ET. To access the live audio webcast, please go to "Events and Presentations" in the Investors section of the Scholar Rock website at http://investors.scholarrock.com. To participate via telephone, please register in advance here. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call. An archived replay of the webcast will be available on the Company's

    2/10/26 8:00:00 AM ET
    $SRRK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amazon.com Announces Fourth Quarter Results

    Amazon.com, Inc. (NASDAQ:AMZN) today announced financial results for its fourth quarter ended December 31, 2025. Fourth Quarter 2025 Net sales increased 14% to $213.4 billion in the fourth quarter, compared with $187.8 billion in fourth quarter 2024. Excluding the $2.8 billion favorable impact from year-over-year changes in foreign exchange rates throughout the quarter, net sales increased 12% compared with fourth quarter 2024. North America segment sales increased 10% year-over-year to $127.1 billion. International segment sales increased 17% year-over-year to $50.7 billion, or increased 11% excluding changes in foreign exchange rates. AWS segment sales increased 24% year-over

    2/5/26 4:01:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Institutional-Grade Token Architecture Positions Companies at the Center of Digital Finance

    Scalable, compliant infrastructure supports demand for regulated digital assets for growing number of industries  Market News Updates News Commentary NEW YORK, Feb. 4, 2026 /PRNewswire/ -- Digital finance is moving fast, and institutional-grade token architecture is becoming a core piece of the financial system. Large investors and institutions want digital assets that are secure, compliant, and easy to integrate with traditional finance. Tokenized infrastructure built for institutions helps make that possible by supporting regulated transactions, asset-backed tokens, and scalable platforms designed for real-world use, not just experimentation as Active Companies take notice that may include

    2/4/26 8:45:00 AM ET
    $COIN
    $DJT
    $GNLN
    Finance: Consumer Services
    Finance
    Computer Software: Programming Data Processing
    Technology

    $AHG
    $AMTI
    $AMZN
    $AREN
    Leadership Updates

    Live Leadership Updates

    View All

    Nuwellis Appoints Carisa Schultz as Chief Financial Officer

    MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE) a medical technology company focused on advancing precision cardiorenal care, today announced the appointment of Carisa Schultz as Chief Financial Officer, effective February 2, 2026. Ms. Schultz brings extensive healthcare and public company finance leadership experience, most recently serving as Vice President of Finance at NeueHealth (formerly Bright Health Group), a healthcare company previously listed on the New York Stock Exchange. In that role, she led enterprise finance, treasury, and corporate development activities. During her tenure at NeueHealth, she also held progressive leadership roles including A

    1/30/26 8:00:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    MediaCo Appoints Maire Mason to Lead Local Radio and Television Operations, Driving Major New York Market Shift

    Veteran Executive Joins MediaCo to Oversee NYC, Chicago, and Denver with Additional Expansion Planned MediaCo Holding Inc. (NASDAQ:MDIA) today announced the appointment of Maire Mason as Vice President and General Manager of Local MediaCo Markets, marking a significant leadership move in the New York radio and television landscape. In this role, Mason will oversee MediaCo's local radio and television operations across New York City, Chicago, and Denver, with responsibility for marquee brands including HOT 97 (WQHT-FM), WBLS-FM, Luna 107.5 (WBLS-HD2), La Buena (WQHT-HD2), and EstrellaTV's WMBC-TV in the New York tri-state area. MediaCo expects Mason's responsibilities to expand to additi

    1/26/26 8:00:00 AM ET
    $MDIA
    Broadcasting
    Consumer Discretionary

    Nuwellis Announces Changes to Board of Directors

    MINNEAPOLIS, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company focused on advancing precision cardiorenal care in critical care settings, today announced the appointment of Katharyn Field and Mika Grasso to its board of directors, effective January 21, 2026. Ms. Field is the Chief Executive Officer of ISpecimen Inc., where she oversees performance improvement and the redevelopment of the proprietary software platform. Prior to serving as Chief Executive Officer she served as President, Chairman, and as an independent director. She has served as a director of LogProstyle since September 2024, as an Executive Director of Akanda Corporation since Ju

    1/23/26 4:40:27 PM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care